Posted by: 2in10 | 01/08/2011


Roche pharmaceuticals announced a new treatment for advanced skin cancer, the first new treatment in 30 years. The drug, known as RG7204 and currently in clinical trials, inhibits a protein mutation found in half of patients with advanced melanoma, according to an article by Jessica Van Sack in The Boston Herald in December 2010 . (I have been saving these articles for you!)

“The results are stunning,” Dr. Severin Schwan, Roche’s CEO, said at a luncheon of the Boston College Chief Executives’ Club. “Literally the tumors are melting away.”

Eighty-one percent of patients had a positive response to the drug and more than half experienced a reduction in tumor size of 30 percent.

“This is not a cure, because we know cancers will escape,” [Schwan] said.

Well, now we need a permanent cure.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: